Patient-Reported Outcomes (Pros) Of Cemiplimab Vs Chemotherapy In Advanced Non-Small Cell Lung Cancer (Ansclc): EMPOWER-Lung 1 Histology Subgroups
| dc.contributor.author | Sezer, A. | |
| dc.contributor.author | Kilickap, S. | |
| dc.contributor.author | Gumus, M. | |
| dc.contributor.author | Bondarenko, I. | |
| dc.contributor.author | Ozguroglu, M. | |
| dc.contributor.author | Gogishvili, M. | |
| dc.contributor.author | He, X. | |
| dc.contributor.author | Gullo, G. | |
| dc.contributor.author | Rietschel, P. | |
| dc.contributor.author | Quek, R. | |
| dc.date.accessioned | 2023-01-02T07:44:13Z | |
| dc.date.available | 2023-01-02T07:44:13Z | |
| dc.date.issued | 2022 | |
| dc.identifier.endpage | 1089 | en_US |
| dc.identifier.issn | 0923-7534 | en_US |
| dc.identifier.issue | 7 | en_US |
| dc.identifier.startpage | 1089 | en_US |
| dc.identifier.uri | https://reader.elsevier.com/reader/sd/pii/S092375342203157X?token=CE440C703142DFD2F8552550E5FFE69B6C4BADA16CE67888407EC9305C61FAC843557A9FCF93829AF385621391C51EF6&originRegion=eu-west-1&originCreation=20230102074310 | |
| dc.identifier.uri | http://hdl.handle.net/11727/8489 | |
| dc.identifier.volume | 33 | en_US |
| dc.identifier.wos | 000866211601445 | en_US |
| dc.language.iso | eng | en_US |
| dc.relation.isversionof | 10.1016/j.annonc.2022.07.1306 | en_US |
| dc.relation.journal | ANNALS OF ONCOLOGY | en_US |
| dc.rights | info:eu-repo/semantics/openAccess | en_US |
| dc.title | Patient-Reported Outcomes (Pros) Of Cemiplimab Vs Chemotherapy In Advanced Non-Small Cell Lung Cancer (Ansclc): EMPOWER-Lung 1 Histology Subgroups | en_US |
| dc.type | Conference Object | en_US |